Massive Transfusion in Pediatric Trauma: Why the 1:1 Ratio Could Save Lives
"New research sheds light on the optimal blood component ratio for massive transfusions in children, potentially improving survival rates in severe trauma cases."
Trauma is the leading cause of death in children. While less frequent than in adults, traumatic injuries often lead to fatalities due to hemorrhage. Rapid intervention is essential, especially in light of the 'lethal triad'—coagulopathy, hypothermia, and acidosis—which complicates hemorrhage in injured children. Quickly addressing these issues improves outcomes, but determining the best strategy to manage coagulopathy from traumatic blood loss remains a challenge.
Transfusing blood components aims to use resources wisely. However, giving unbalanced blood products can worsen coagulopathy, especially when many transfusions are needed quickly. Massive Transfusion Protocols (MTPs) allow blood products to be given rapidly in fixed ratios. There's a lot of research on the best MTP makeup for adults. These studies try to reduce coagulopathy and death. The suggested ratios vary, with some centers using a 1:1:1 ratio of packed red blood cells (pRBC), fresh frozen plasma (FFP), and platelets (PLT), similar to combat support hospitals. Others use a 10:4:2 ratio, which has been successful in civilian trauma centers. While the ideal ratio for adults is still debated, evidence shows that using MTPs improves results for adults with severe trauma.
In situations involving significant blood loss, replacing intravascular volume is crucial to sustain organ function. While both crystalloid and colloid fluids can quickly expand volume, excessive use of intravenous fluids diminishes the blood's oxygen-carrying capacity and clotting ability through dilution, among other potential mechanisms. Shock and coagulopathy are known contributors to mortality and morbidity in trauma, independent of the patient's injury severity. The current approach to trauma care, known as 'damage control resuscitation,' involves component administration to minimize coagulopathy while maximizing oxygen-carrying capacity. However, the optimal blood component ratio for children remains unknown.
The 1:1 pRBC:FFP Ratio: A Game-Changer for Pediatric Trauma?

A multi-center retrospective study from the ATOMAC (Arizona, Texas, Oklahoma, Memphis, Arkansas Consortium) Level I Pediatric Trauma Centers (PTC) provides crucial insights into massive transfusions in pediatric trauma patients. The study reviewed data from January 1, 2007, to December 31, 2013, including children up to 18 years old who received at least two units of pRBCs, 20ml/kg of pRBCs, or underwent an institutional massive transfusion protocol within 24 hours of injury. The analysis focused on blood products administered within this initial 24-hour window, excluding patients requiring extra-corporeal life support.
- Highest Survival: Children receiving a 1:1 pRBC:FFP ratio had the highest survival rates.
- Increased Mortality Risk: Ratios of 2:1 or ≥3:1 were linked to a significantly increased risk of death.
- Age Independence: The 1:1 ratio's benefit remained consistent across different age groups, addressing concerns that younger children might need different ratios due to their unique coagulation profiles.
The Future of Pediatric Trauma Care: Implementing Optimal Transfusion Protocols
This research underscores the need for standardized massive transfusion protocols (MTPs) that prioritize a 1:1 pRBC:FFP ratio in pediatric trauma settings. Implementing such protocols can improve product availability, speed up transfusions, reduce reliance on lab results, and simplify decision-making during critical situations.
The study also advocates for a reevaluation of the definition of massive transfusion in children. The traditional threshold of >40ml/kg of blood products within 24 hours may be too high, delaying the implementation of potentially life-saving MTPs. A lower threshold could encourage earlier intervention and better outcomes.
While these findings are promising, prospective randomized multi-center trials are needed to confirm these results and refine the definition of massive transfusion in pediatrics. Further research will help to optimize blood component ratios and improve survival rates for severely injured children, ultimately transforming pediatric trauma care.